Ciglitazone - CISMeF

Preferred Label : Ciglitazone;

NCIt definition : An agent belonging to the glitazone (thiazolidinedione) class of antidiabetic agents with antihyperglycemic activity. Ciglitazone also exerts anti-inflammatory activity through the modulation of nuclear factor-kappaB-mediated pathways. In addition, this agent inhibits angiogenesis by reducing vascular endothelial growth factor (VEGF) production and inhibits growth of melanoma cells by inhibiting the expression of (C-X-C motif) ligand 1 (CXCL1). This agent is the prototypical compound for the thiazolidinedione class, and has never been marketed.;

UNII : U8QXS1WU8G;

InChIKey : YZFWTZACSRHJQD-UHFFFAOYSA-N;

CAS number : 74772-77-3;

Chemical formula : C18H23NO3S;

ChEBI ID : CHEBI:64227;

Details

Origin ID

C72726;

UMLS CUI

C0055721;

Currated CISMeF NLP mapping
- ciglitazone [MeSH concept]
- ciglitazone [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- ciglitazone [MeSH concept]
- ciglitazone [MeSH Supplementary Concept]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients